🚀 VC round data is live in beta, check it out!

Kenvue Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kenvue and similar public comparables like Estee Lauder, Henkel, Ulta Beauty, Galderma and more.

Kenvue Overview

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.


Founded

2022

HQ

United States

Employees

22.0K

Website

kenvue.com

Financials (LTM)

Revenue: $15B
EBITDA: $3B

EV

$44B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Kenvue Financials

Kenvue reported last 12-month revenue of $15B and EBITDA of $3B.

In the same LTM period, Kenvue generated $9B in gross profit, $3B in EBITDA, and $2B in net income.

Revenue (LTM)


Kenvue P&L

In the most recent fiscal year, Kenvue reported revenue of $15B and EBITDA of $3B.

Kenvue expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Kenvue forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$15BXXX$15BXXXXXXXXX
Gross Profit$9BXXX$9BXXXXXXXXX
Gross Margin60%XXX58%XXXXXXXXX
EBITDA$3BXXX$3BXXXXXXXXX
EBITDA Margin23%XXX23%XXXXXXXXX
EBIT Margin21%XXX21%XXXXXXXXX
Net Profit$2BXXX$2BXXXXXXXXX
Net Margin14%XXX14%XXXXXXXXX
Net Debt——$7BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Kenvue Stock Performance

Kenvue has current market cap of $36B, and enterprise value of $44B.

Market Cap Evolution


Kenvue's stock price is $18.89.

See Kenvue trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$44B$36B0.0%XXXXXXXXX$1.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Kenvue Valuation Multiples

Kenvue trades at 2.9x EV/Revenue multiple, and 12.6x EV/EBITDA.

See valuation multiples for Kenvue and 15K+ public comps

EV / Revenue (LTM)


Kenvue Financial Valuation Multiples

As of April 5, 2026, Kenvue has market cap of $36B and EV of $44B.

Equity research analysts estimate Kenvue's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Kenvue has a P/E ratio of 17.2x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$36BXXX$36BXXXXXXXXX
EV (current)$44BXXX$44BXXXXXXXXX
EV/Revenue2.9xXXX2.9xXXXXXXXXX
EV/EBITDA12.6xXXX12.8xXXXXXXXXX
EV/EBIT13.7xXXX13.8xXXXXXXXXX
EV/Gross Profit4.8xXXX5.0xXXXXXXXXX
P/E17.2xXXX17.4xXXXXXXXXX
EV/FCF21.4xXXX21.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Kenvue Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Kenvue Margins & Growth Rates

Kenvue's revenue in the last 12 month grew by 3%.

Kenvue's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.

Kenvue's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kenvue's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kenvue and other 15K+ public comps

Kenvue Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth3%XXX3%XXXXXXXXX
EBITDA Margin23%XXX23%XXXXXXXXX
EBITDA Growth5%XXX5%XXXXXXXXX
Rule of 40—XXX26%XXXXXXXXX
Bessemer Rule of X—XXX30%XXXXXXXXX
Revenue per Employee—XXX$0.7MXXXXXXXXX
Opex per Employee—XXX$0.3MXXXXXXXXX
Opex to Revenue—XXX40%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Kenvue Public Comps

See public comps and valuation multiples for other Health & Beauty comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Estee LauderXXXXXXXXXXXXXXXXXX
HenkelXXXXXXXXXXXXXXXXXX
Ulta BeautyXXXXXXXXXXXXXXXXXX
GaldermaXXXXXXXXXXXXXXXXXX
HaleonXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Kenvue M&A Activity

Kenvue acquired XXX companies to date.

Last acquisition by Kenvue was on XXXXXXXX, XXXXX. Kenvue acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Kenvue

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Kenvue Investment Activity

Kenvue invested in XXX companies to date.

Kenvue made its latest investment on XXXXXXXX, XXXXX. Kenvue invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Kenvue

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Kenvue

When was Kenvue founded?Kenvue was founded in 2022.
Where is Kenvue headquartered?Kenvue is headquartered in United States.
How many employees does Kenvue have?As of today, Kenvue has over 22K employees.
Who is the CEO of Kenvue?Kenvue's CEO is Kirk L. Perry.
Is Kenvue publicly listed?Yes, Kenvue is a public company listed on NYSE.
What is the stock symbol of Kenvue?Kenvue trades under KVUE ticker.
When did Kenvue go public?Kenvue went public in 2023.
Who are competitors of Kenvue?Kenvue main competitors are Estee Lauder, Henkel, Ulta Beauty, Galderma.
What is the current market cap of Kenvue?Kenvue's current market cap is $36B.
What is the current revenue of Kenvue?Kenvue's last 12 months revenue is $15B.
What is the current revenue growth of Kenvue?Kenvue revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Kenvue?Current revenue multiple of Kenvue is 2.9x.
Is Kenvue profitable?Yes, Kenvue is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Kenvue?Kenvue's last 12 months EBITDA is $3B.
What is Kenvue's EBITDA margin?Kenvue's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Kenvue?Current EBITDA multiple of Kenvue is 12.6x.
What is the current FCF of Kenvue?Kenvue's last 12 months FCF is $2B.
What is Kenvue's FCF margin?Kenvue's last 12 months FCF margin is 13%.
What is the current EV/FCF multiple of Kenvue?Current FCF multiple of Kenvue is 21.4x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial